These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Irregular antibodies: an assessment of routine prenatal screening. Solola A; Sibai B; Mason JM Obstet Gynecol; 1983 Jan; 61(1):25-30. PubMed ID: 6401853 [TBL] [Abstract][Full Text] [Related]
5. Haemolytic disease of newborn. Narang A; Jain N Indian J Pediatr; 2001 Feb; 68(2):167-72. PubMed ID: 11284186 [TBL] [Abstract][Full Text] [Related]
6. Is antenatal antibody screening worthwhile in the Zimbabwean population? Verkuyl DA Cent Afr J Med; 2001 Jan; 47(1):26-8; author reply 28. PubMed ID: 11961856 [No Abstract] [Full Text] [Related]
7. A case for the antenatal administration of anti-D immunoglobulin to primigravidae. Tovey LA; Taverner JM Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301 [TBL] [Abstract][Full Text] [Related]
8. Prevention of haemolytic disease of the newborn due to anti-D. Tovey G; Wagstaff W Br Med J (Clin Res Ed); 1981 Jul; 283(6284):142. PubMed ID: 6266575 [No Abstract] [Full Text] [Related]
9. Determination of fetal RHD type in plasma of RhD negative pregnant women. Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532 [TBL] [Abstract][Full Text] [Related]
10. Rh(D) haemolytic disease of the newborn: the changing scene. Urbaniak SJ Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630 [No Abstract] [Full Text] [Related]
11. Frequency and clinical significance of red cell antibodies in pregnancy - A prospective study from India. Das S; Shastry S; Rai L; Baliga PB Indian J Pathol Microbiol; 2020; 63(2):241-246. PubMed ID: 32317523 [TBL] [Abstract][Full Text] [Related]
12. The incidence and outcome of clinically significant antibodies detected in Rhesus-D positive pregnant women of the Northern Territory. Andersson L; Szabo F Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):514-517. PubMed ID: 29192961 [TBL] [Abstract][Full Text] [Related]
13. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers. Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437 [TBL] [Abstract][Full Text] [Related]
14. Management of pregnancy complicated by anti-hrB/anti-HrB. Win N; Needs M; Tillyer L Immunohematology; 2007; 23(4):143-5. PubMed ID: 18284303 [TBL] [Abstract][Full Text] [Related]
16. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis. Lee D BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614 [No Abstract] [Full Text] [Related]
17. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative. Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602 [TBL] [Abstract][Full Text] [Related]
18. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin. Branch DR; Scofield TL; Moulds JJ; Swanson JL Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183 [TBL] [Abstract][Full Text] [Related]
19. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women. Karim F; Moiz B; Kamran N Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis. Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]